A webinar sponsored by Astrix   

Date: June 26, 2024

Time:  1:00 PM EST / 10:00 AM PST

Presented by:  Brendan McCorkle, CEO, SciNote and Luke Cach, Sales Director, Ganymede 

Overview:

A key milestone in drug discovery is the successful transition from R&D into manufacturing. Bioprocessing plays a critical role in this journey.

As more pharmaceutical companies bring bioprocessing in-house, relying less on external CROs, traditional research or manufacturing-centric electronic lab notebooks (ELNs) are proving inadequate. Bioprocessing demands a flexible, scalable solution that maintains the necessary structure while meeting stringent regulatory requirements.

In this webinar, Brendan McCorkle (CEO, SciNote) and Luke Cach (Sales Director, Ganymede) will leverage their experiences in data management and bioprocessing, and discuss how an ELN solution that supports flexible workflows can bridge the gap between R&D and manufacturing. Join us to discover how you can streamline your bioprocessing workflows while ensuring compliance and scalability.

About Astrix

Astrix is the unrivaled market-leader in creating & delivering innovative strategies, solutions, and people to the life science community.  Through world class people, process, and technology, Astrix works with clients to fundamentally improve business & scientific outcomes and the quality of life everywhere. Founded by scientists to solve the unique challenges of the life science community, Astrix offers a growing array of strategic, technical, and staffing services designed to deliver value to clients across
their organizations.